𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparison of human prostate specific glandular kallikrein 2 and prostate specific antigen gene expression in prostate with gene amplification and overexpression of prostate specific glandular kallikrein 2 in tumor tissue

✍ Scribed by Annakaisa M. Herrala; Katja S. Porvari; Atte P. Kyllönen; Pirkko T. Vihko

Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
982 KB
Volume
92
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

The authors thank Liisa Kaarela, Helmi Konola, and Mirja Ma ¨kela ¨inen for their expert technical assistance and Risto Bloigu for helping with the statistical analysis.

📜 SIMILAR VOLUMES

Expression of prostate-specific antigen
Expression of prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues
✍ A. Yvonne Olsson; Anders Bjartell; Hans Lilja; Åke Lundwall 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 396 KB

## Abstract Prostate‐specific antigen (PSA) is a widely used marker for prostate cancer. In the literature, there are reports of nonprostatic expression of PSA that potentially can affect early diagnosis. However, the results are scattered and inconclusive, which motivated us to conduct a more comp

The importance of human glandular kallik
The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma
✍ Franz Recker; Maciej K. Kwiatkowski; Timo Piironen; Kim Pettersson; Gerd Lümmen; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 2 views

## BACKGROUND. Human glandular kallikrein (hK2), the prostate specific antigen (PSA) close homologue, possesses approximately 80% structure identity with PSA. The identification of PSA was an important step in the detection of prostate carcinoma (PCa). Thus, hK2 measurement in the serum has the po

Expression of the gene coding for human
Expression of the gene coding for human prostate-specific antigen and related hGK-1 in benign and malignant tumors of the human prostate
✍ P. Henttu; O. Lukkarinen; P. Vihko 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 934 KB

Human glandular kallikrein-I gene (hGK-I) is closely related to the gene of human prostate-specific antigen (PSA) and both genes are expressed in the human prostate. We have studied PSA and hGK-I mRNAs in human prostatic tissue samples from patients with benign prostatic hyperplasia (BPH) or adenoca

Evaluation of molecular forms of prostat
Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy
✍ Sven Wenske; Ruslan Korets; Angel M. Cronin; Andrew J. Vickers; Martin Fleisher; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 83 KB 👁 1 views

## Abstract Most pretreatment risk‐assessment models to predict biochemical recurrence (BCR) after radical prostatectomy (RP) for prostate cancer rely on total prostate‐specific antigen (PSA), clinical stage, and biopsy Gleason grade. We investigated whether free PSA (fPSA) and human glandular kall

Different proportions of various prostat
Different proportions of various prostate-specific antigen (PSA) and human kallikrein 2 (hK2) forms are present in noninduced and androgen-induced LNCaP cells
✍ Abhay Kumar; Stephen D. Mikolajczyk; Timothy M. Hill; Lisa S. Millar; Mohammad S 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 229 KB

## BACKGROUND. Human prostate-specific antigen (PSA) and human kallikrein 2 (hK2) are expressed primarily by prostate epithelial cells. PSA and hK2 both exist as free protein and complexed with protease inhibitors (e.g., ␣1-antichymotrypsin, ACT) in serum. The expression of PSA and hK2 in LNCaP ce

Risk assessment for biochemical recurren
Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum
✍ Thomas Steuber; Andrew J. Vickers; Alexander Haese; Charlotte Becker; Kim Petter 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 122 KB

## Abstract Most models to predict biochemical recurrence (BCR) of prostate cancer use pretreatment serum prostate‐specific antigen (PSA), clinical stage and prostate biopsy Gleason grade. We investigated whether human glandular kallikrein 2 (hK2) and free prostate‐specific antigen (fPSA) measured